| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| AMPK | AMP-activated protein kinase |
| ARE | Antioxidant response element |
| cIAP | Cellular inhibitor of apoptosis protein |
| CREB | cAMP response element-binding protein |
| CYLD | Cylindromatosis |
| DAMP | Damage-associated molecular pattern |
| FADD | FAS-associated death domain |
| HMGB1 | High mobility group box 1 |
| HO-1 | Heme oxygenase-1 |
| DO | Indoleamine 2,3-dioxygenase |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| LDH | Lactate dehydrogenase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MLKL | Mixed lineage kinase domain-like protein |
| MMP | Matrix metalloproteinase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MS | Multiple sclerosis |
| Nec-1 | Necrostatin-1 |
| Nec-1s | Necrostatin-1 stable |
| NEMO | NF-κB essential modulator |
| Nrf2 | Nuclear factor-erythroid 2 (NF-E2)-related factor |
| 6-OHDA | 6-hydroxydopamine |
| PD | Parkinson’s disease |
| RIPK | Receptor-interacting protein kinase |
| ROS | Reactive oxygen species |
| SN | Substantia nigra |
| TH | Tyrosine hydroxylase |
| TLR | Toll-like receptor |
| TNFR | Tumor necrosis factor receptor |